Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) Income from Continuing Operations (2024 - 2025)

Historic Income from Continuing Operations for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to -$17.2 million.

  • Connect Biopharma Holdings' Income from Continuing Operations fell 3358.19% to -$17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.3 million, marking a year-over-year change of. This contributed to the annual value of -$15.6 million for FY2024, which is 7483.66% up from last year.
  • According to the latest figures from Q3 2025, Connect Biopharma Holdings' Income from Continuing Operations is -$17.2 million, which was down 3358.19% from -$12.9 million recorded in Q2 2025.
  • Connect Biopharma Holdings' Income from Continuing Operations' 5-year high stood at $14.8 million during Q2 2024, with a 5-year trough of -$17.2 million in Q3 2025.